Managing diabetic peripheral neuropathic pain in primary care

Journal of Family Practice

Volumn 59, Issue SUPPL. 5, 2010, Pages

  Kuritzky, Louis ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; CAPSAICIN; CARBAMAZEPINE; CITALOPRAM; DESIPRAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DULOXETINE; GABAPENTIN; HYDROMORPHONE; IMIPRAMINE; LAMOTRIGINE; LEVORPHANOL; LIDOCAINE; METHADONE; MEXILETINE; MORPHINE; NORTRIPTYLINE; OXCARBAZEPINE; OXYCODONE; PAROXETINE; PHENYTOIN; PREGABALIN; TOPIRAMATE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID; VASODILATOR AGENT; VENLAFAXINE;

BEDTIME DOSAGE; CLINICAL FEATURE; DIABETIC NEUROPATHY; DIABETIC PERIPHERAL NEUROPATHIC PAIN; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; HUMAN; NEUROPATHIC PAIN; PATHOGENESIS; PHYSICAL EXAMINATION; REVIEW; SLEEP DISORDER; TREATMENT DURATION; TREATMENT RESPONSE;

ACETYLCARNITINE; ANALGESICS; ANTIDEPRESSIVE AGENTS; DIABETIC NEUROPATHIES; DRUG THERAPY, COMBINATION; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; NEUROLOGIC EXAMINATION; PATIENT EDUCATION AS TOPIC; PRIMARY HEALTH CARE; THIOCTIC ACID; VITAMIN B COMPLEX;

EID: 77952411487     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Diabetes Information Library. American Diabetes Association survey finds most people with diabetes don't know about highly prevalent serious complications. http://www.diabeteslibrary.org/PrintArticle.aspx?ArticleID=675. Accessed January 5, 2010.
2. Daousi C, MacFarlane IA, Woodward A, et al. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med. 2004;21:976-982. (Pubitemid 39215316)
3. McDermott AM, Toelle TR, Rowbotham DJ, et al. The burden of neuropathic pain: results from a cross-sectional survey. Eur J Pain. 2006;10:127-135.
4. Gore M, Brandenburg NA, Hoffman DL, et al. Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives. J Pain. 2006;7:892-900. (Pubitemid 44854739)
5. Gore M, Brandenburg NA, Dukes E, et al. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. J Pain Symptom Manage. 2005;30:374-385.
6. Resnick HE, Carter EA, Sosenko JM, et al; Strong Heart Study. Incidence of lower-extremity amputation in American Indians: the Strong Heart Study. Diabetes Care. 2004;27:1885-1891.
7. Young MJ, McCardle JE, Randall LE, et al. Improved survival of diabetic foot ulcer patients 1995-2008: possible impact of aggressive cardiovascular risk management. Diabetes Care. 2008;31:2143-2147.
8. Tesfaye S, Harris ND, Wilson RM, et al. Exercise-induced conduction velocity increment: a marker of impaired peripheral nerve blood flow in diabetic neuropathy. Diabetologia. 1992;35:155-159.
9. Harati Y. Diabetic neuropathies: unanswered questions. Neurol Clin. 2007;25:303-317.
10. Boulton AJ, Malik RA, Arezzo JC, et al. Diabetic somatic neuropathies. Diabetes Care. 2004;27:1458-1486.
11. Bansal V, Kalita J, Misra UK. Diabetic neuropathy. Postgrad Med J. 2006;82:95-100.
12. Boulton AJ, Vinik AI, Arezzo JC, et al; American Diabetes Association. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005;28:956-962.
13. Elliott J, Tesfaye S, Chaturvedi N, et al; EURODIAB Prospective Complications Study Group. Large-fiber dysfunction in diabetic peripheral neuropathy is predicted by cardiovascular risk factors. Diabetes Care. 2009;32:1896-1900.
14. Argoff CE, Cole BE, Fishbain DA, et al. Diabetic peripheral neuropathic pain: clinical and quality-of-life issues. Mayo Clin Proc. 2006;81(4 suppl):S3-S11.
15. Gorson KC, Ropper AH. Additional causes for distal sensory polyneuropathy in diabetic patients. J Neurol Neurosurg Psychiatry. 2006;77:354-358.
16. Meijer JW, Smit AJ, Lefrandt JD, et al. Back to basics in diagnosing diabetic polyneuropathy with the tuning fork! Diabetes Care. 2005;28:2201-2205.
17. Bennett M. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain. 2001;92:147-157.
18. Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology. 1997;48:332-338.
19. Krause SJ, Backonja MM. Development of a neuropathic pain questionnaire. Clin J Pain. 2003;19:306-314.
20. Zelman DC, Gore M, Dukes E, et al. Validation of a modified version of the brief pain inventory for painful diabetic peripheral neuropathy. J Pain Symptom Manage. 2005;29:401-410. (Pubitemid 40602521)
21. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
22. Ziegler D, Nowak H, Kempler P, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med. 2004;21:114-121.
23. Ametov AS, Barinov A, Dyck PJ, et al; SYDNEY Trial Study Group. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. Diabetes Care. 2003;26:770-776.
24. Ziegler D, Ametov A, Barinov A, et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care. 2006;29:2365-2370.
25. Sima AA, Calvani M, Mehra M, et al. Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials. Diabetes Care. 2005;28:89-94.
26. Argoff CE, Backonja MM, Belgrade MJ, et al. Consensus guidelines: treatment planning and options. Diabetic peripheral neuropathic pain. Mayo Clin Proc. 2006;81(4 suppl):S12-S25.
27. Argoff CE, Backonja MM, Belgrade MJ, et al. Diabetic peripheral neuropathic pain. Consensus guidelines for treatment. J Fam Pract. 2006;(suppl):1-20.
28. Dworkin RH, O'Connor AB, Backonja M, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain. 2007;132:237-251.
29. Ziegler D. Treatment of diabetic neuropathy and neuropathic pain: how far have we come? Diabetes Care. 2008;31(suppl 2):S255-S261.
30. Hirsh J, Bhatt DL. Comparative benefits of clopidogrel and aspirin in high-risk patient populations: lessons from the CAPRIE and CURE studies. Arch Intern Med. 2004;164:2106-2110.
31. Cymbalta [prescribing information]. Indianapolis, IN: Eli Lilly and Company; 2009.
32. Neurontin [prescribing information]. New York, NY: Parke-Davis; 2009.
33. Lyrica [prescribing information]. New York, NY: Parke-Davis; 2009.
34. Oxycontin [prescribing information]. Stamford, CT: Purdue Pharma L.P.; 2007.
35. Ultram [prescribing information]. Raritan, NJ: Ortho-McNeil Pharmaceuticals, Inc.; 2008.